Genetic testing technologies are evolving at a rapid pace. Consequently, their capabilities and limitations are also quickly changing.
In this webinar, Laboratory Director and Senior Geneticist Jennifer Schleit (PhD, FACMG) will review and discuss common questions and misconceptions about genetic testing. Topics include copy number detection using NGS-based technology, using diagnostic yield as a metric for test quality, and limitations of genetic testing. Where possible, case examples and testing data will be used to confirm or debunk these myths.
- Critically evaluate NGS-based genetic testing capabilities and limitations
- Provide insights to support informed decision-making when selecting the best laboratory and test for your patient
- Demonstrate clinical significance through case examples
- Discuss the future of genetic testing capabilities
Dr Jennifer Schleit (PhD, FACMG) received a Bachelor of Science with Honours in Biochemistry and Microbiology from Dalhousie University and a PhD in Pathology from the University of Washington in Seattle, Washington, USA. She completed a clinical fellowship at the University of Washington and received her certification in clinical molecular genetics from the American Board of Medical Genetics and Genomics (ABMGG). Dr Schleit served as an Assistant Director at the Center for Precision Diagnostics at the University of Washington before accepting a position as Senior Geneticist at Blueprint Genetics in 2017. Currently, she is the Laboratory Director of the Seattle facility.
More details here